5088.0: Wednesday, October 24, 2001 - 1:00 PM

Abstract #30996

Botanicals of Relevance to the Treatment of Syndrome X and Component Abnormalities

David DeRose, MD, MPH, Zeno L. Charles-Marcel, MD, Phylis Austin, BS, and Timothy J. Arnott, MD. Lifestyle Center of America, Rt 1, Box 4001, Goddard Youth Camp Road, Sulphur, OK 73086, 580-993-2327, drderose@brightok.net

Syndrome X, also referred to as the "cardiovascular dysmetabolic syndrome" or the "polymetabolic syndrome," refers to a constellation of findings that includes insulin resistance, high triglycerides, low HDL cholesterol, and high blood pressure. Furthermore, a number of other conditions such as diabetes and obesity often occur in association with Syndrome X.

Lifestyle intervention is considered to be fundamental to treating Syndrome X. However, the use of botanical preparations for Syndrome X is of increasing public health importance for a number of reasons. First, Syndrome X and component abnormalities are steadily increasing in prevalence. Second, a number of botanical preparations hold potential to modulate Syndrome X, its related risk factors, and allied conditions. Third, the prevalent and increasing use of botanicals to treat the component abnormalities of Syndrome X, alongside pharmacological treatments, increases the likelihood of herb-drug interactions. Concerns for interactions with anticoagulants are of particular relevance.

Learning Objectives: Describe at least four clinical features of Syndrome X; identify at least four botanical compounds that may modulate Syndrome X and related conditions; discuss major concerns for herb/drug interactions when attempting to address Syndrome X with botanicals.

Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: None
I have a significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.
Relationship:

The 129th Annual Meeting of APHA